BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34189453)

  • 1. Seizure control after late introduction of anakinra in a patient with adult onset Rasmussen's encephalitis.
    Mochol M; Taubøll E; Sveberg L; Tennøe B; Berg Olsen K; Heuser K; Svalheim S
    Epilepsy Behav Rep; 2021; 16():100462. PubMed ID: 34189453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rasmussen's syndrome treated with anakinra.
    Arcan A; Kızılkılıç EK; Gündüz A; Unkun R; Vezzani A; Özkara Ç
    J Neurol; 2024 Feb; 271(2):723-726. PubMed ID: 37922068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation, diagnosis and treatment of bilateral Rasmussen's encephalitis in a 12-year-old female.
    Peariso K; Standridge SM; Hallinan BE; Leach JL; Miles L; Mangano FT; Greiner HM
    Epileptic Disord; 2013 Sep; 15(3):324-32. PubMed ID: 23917753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
    Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
    Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset Rasmussen's encephalitis with triple pathology.
    Cheong JY; Wong C; Bleasel A; Varikatt W; Ng T; Dexter MA
    J Clin Neurosci; 2009 Dec; 16(12):1677-81. PubMed ID: 19800797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Globally altered microstructural properties and network topology in Rasmussen's encephalitis.
    Held NR; Bauer T; Reiter JT; Hoppe C; Keil VCW; Radbruch A; Helmstaedter C; Surges R; Rüber T
    Brain Commun; 2023; 5(6):fcad290. PubMed ID: 37953836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good outcome in adult-onset Rasmussen's encephalitis syndrome: is recovery possible?
    Poloni TE; Galli A; Pichiecchio A; di Lodovico L; Ceroni M
    Epileptic Disord; 2015 Jun; 17(2):204-8. PubMed ID: 25906060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-responsive neurostimulation in adult-onset rasmussen's encephalitis.
    Feyissa AM; Mohamed AS; Tatum WO; Campbell AS; Lopez-Chiriboga AS
    Epilepsy Behav Rep; 2021; 15():100445. PubMed ID: 33912823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vagus nerve stimulator treatment in adult-onset Rasmussen's encephalitis.
    Grujic J; Bien CG; Pollo C; Rossetti AO
    Epilepsy Behav; 2011 Jan; 20(1):123-5. PubMed ID: 21130042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset Rasmussen's encephalitis and long-term remission.
    Kupila L; Jutila L; Immonen A; Vanninen R; Mervaala E; Pateau A; Luostarinen L; Kälviäinen R
    Epileptic Disord; 2011 Mar; 13(1):88-91. PubMed ID: 21393098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthetic Management with Propofol in a Patient with Rasmussen's Encephalitis Complicated by Intractable Partial-Onset Epileptic Seizures: A Case Report.
    Akazawa M; Yan G; Hirai R; Kitagawa H
    Case Rep Neurol; 2023; 15(1):233-237. PubMed ID: 38022391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua.
    Takahashi Y; Mori H; Mishina M; Watanabe M; Kondo N; Shimomura J; Kubota Y; Matsuda K; Fukushima K; Shiroma N; Akasaka N; Nishida H; Imamura A; Watanabe H; Sugiyama N; Ikezawa M; Fujiwara T
    Epilepsia; 2005; 46 Suppl 5():152-8. PubMed ID: 15987271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial direct current stimulation in adolescent and adult Rasmussen's encephalitis.
    San-Juan D; Calcáneo Jde D; González-Aragón MF; Bermúdez Maldonado L; Avellán AM; Argumosa EV; Fregni F
    Epilepsy Behav; 2011 Jan; 20(1):126-31. PubMed ID: 21167786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies.
    Steinhoff BJ; Patten A; Williams B; Malhotra M
    Epilepsia; 2020 Feb; 61(2):278-286. PubMed ID: 31944276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical Rasmussen's encephalitis treated with temporal lobectomy.
    Abd-El-Barr MM; Wu B; Rahman M; Yachnis AT; Roper SN; Eisenschenk S
    J Clin Neurosci; 2011 Feb; 18(2):287-90. PubMed ID: 21163652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rasmussen's encephalitis followed by lupus erythematosus.
    Lascelles K; Dean AF; Robinson RO
    Dev Med Child Neurol; 2002 Aug; 44(8):572-4. PubMed ID: 12206625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.
    Rogers SW; Andrews PI; Gahring LC; Whisenand T; Cauley K; Crain B; Hughes TE; Heinemann SF; McNamara JO
    Science; 1994 Jul; 265(5172):648-51. PubMed ID: 8036512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of Rasmussen's Encephalitis: A systematic review.
    Lagarde S; Boucraut J; Bartolomei F
    Rev Neurol (Paris); 2022 Sep; 178(7):675-691. PubMed ID: 35131107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic focal encephalitis (Rasmussen's syndrome) in an adult.
    Yeh PS; Lin CN; Lin HJ; Tsai TC
    J Formos Med Assoc; 2000 Jul; 99(7):568-71. PubMed ID: 10925569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Diagnosis and Treatment of Rasmussen's Encephalitis: A Case Report.
    Jadhav SS; Dhok AP; Mitra KR; Ambhore AN
    Cureus; 2023 Jan; 15(1):e34075. PubMed ID: 36843695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.